Systemic treatment with 7,8-Dihydroxiflavone activates TtkB and affords protection of two different retinal ganglion cell populations against axotomy in adult rats

2021 ◽  
pp. 108694
Author(s):  
Beatriz Vidal-Villegas ◽  
Johnny Di Pierdomenico ◽  
Alejandro Gallego-Ortega ◽  
Caridad Galindo-Romero ◽  
Jose M. Martínez-de-la-Casa ◽  
...  
2016 ◽  
Vol 146 ◽  
pp. 370-385 ◽  
Author(s):  
Adam Hedberg-Buenz ◽  
Mark A. Christopher ◽  
Carly J. Lewis ◽  
Kimberly A. Fernandes ◽  
Laura M. Dutca ◽  
...  

Development ◽  
1999 ◽  
Vol 126 (13) ◽  
pp. 2967-2978 ◽  
Author(s):  
A. Picker ◽  
C. Brennan ◽  
F. Reifers ◽  
J.D. Clarke ◽  
N. Holder ◽  
...  

The organizer at the midbrain-hindbrain boundary (MHB organizer) has been proposed to induce and polarize the midbrain during development. We investigate the requirement for the MHB organizer in acerebellar mutants, which lack a MHB and cerebellum, but retain a tectum, and are mutant for fgf8, a candidate inducer and polarizer. We examine the retinotectal projection in the mutants to assay polarity in the tectum. In mutant tecta, retinal ganglion cell (RGC) axons form overlapping termination fields, especially in the ventral tectum, and along both the anterior-posterior and dorsal-ventral axis of the tectum, consistent with a MHB requirement in generating midbrain polarity. However, polarity is not completely lost in the mutant tecta, in spite of the absence of the MHB. Moreover, graded expression of the ephrin family ligand Ephrin-A5b is eliminated, whereas Ephrin-A2 and Ephrin-A5a expression is leveled in acerebellar mutant tecta, showing that ephrins are differentially affected by the absence of the MHB. Some RGC axons overshoot beyond the mutant tectum, suggesting that the MHB also serves a barrier function for axonal growth. By transplanting whole eye primordia, we show that mapping defects and overshooting largely, but not exclusively, depend on tectal, but not retinal genotype, and thus demonstrate an independent function for Fgf8 in retinal development. The MHB organizer, possibly via Fgf8 itself, is thus required for midbrain polarisation and for restricting axonal growth, but other cell populations may also influence midbrain polarity.


1993 ◽  
Vol 24 (1) ◽  
pp. 23-36 ◽  
Author(s):  
Maria-Paz Villegas-Pérez ◽  
Manuel Vidal-Sanz ◽  
Michael Rasminsky ◽  
Garth M. Bray ◽  
Albert J. Aguayo

Pharmaceutics ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 893
Author(s):  
Xian Zhang ◽  
Nan Zhang ◽  
Micah A. Chrenek ◽  
Preston E. Girardot ◽  
Jiaxing Wang ◽  
...  

Glaucoma etiology often includes retinal ganglion cell (RGC) death associated with elevated intraocular pressure (IOP). However, even when IOP is managed well, disease can progress. It is thus important to develop therapeutic approaches that directly protect RGCs in an IOP-independent manner. Compromised nicotinamide adenine dinucleotide (NAD+) metabolism occurs in neurodegenerative diseases, including models of glaucoma. Here we report testing the protective effects of prophylactically systemically administered nicotinamide riboside (NR), a NAD+ precursor, in a mouse model of acute RGC damage (optic nerve crush (ONC)), and in a chronic model of RGC degeneration (ocular hypertension induced by intracameral injection of microbeads). For both models, treatment enhanced RGC survival, assessed by counting cells in retinal flatmounts immunostained for Brn3a+. In the ONC model, treatment preserved RGC function, as assessed by pattern electroretinogram, and suppressed retinal inflammation, as assessed by immunofluorescence staining of retinal fixed sections for glial fibrillary acidic protein (GFAP). This is the first study to demonstrate that systemic treatment with NR is protective in acute and chronic models of RGC damage. The protection is significant and, considering that NR is highly bioavailable in and well-tolerated by humans, may support the proposition of prospective human subject studies.


2009 ◽  
Vol 49 (1) ◽  
pp. 115-126 ◽  
Author(s):  
M. Salinas-Navarro ◽  
S. Mayor-Torroglosa ◽  
M. Jiménez-López ◽  
M. Avilés-Trigueros ◽  
T.M. Holmes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document